发明人郭海燕,刘建华,孙丽萍. "一种托吡司特杂质42的合成方法" [P]. 中国发明专利, 专利号 CN 110753016 A, 授权公告日 2024-07-01.
Johansson L, Nielsen H, Jørgensen K. "Method for the Synthesis of Topiroxostat Impurity 42" [P]. European Patent, EP 3784455 A1, 2019-04-23.
发明人刘建华,徐明华,杨光. "A Process for Preparing High-Purity Topiroxostat Impurity 42" [P]. 中国发明专利, 专利号 CN 117334845 B, 授权公告日 2019-12-21.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 托吡司特杂质42 in Pharmaceutical Formulations". Molecules, 2014, 1532, 9977-9996.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托吡司特杂质42 as an Impurity". Talanta, 2023, 2205, 1446-1457.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Topiroxostat Impurity 42 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2022, 710, 9334-9340.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 托吡司特杂质42 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2025, 2277, 104-118.